These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1651564)

  • 21. Studies on platelet aggregation and antiplatelet therapy in blackfoot disease.
    Chen WY; Lee FN; Hsieh BS; Yen TS; Chou JH
    Taiwan Yi Xue Hui Za Zhi; 1981 Sep; 80(9):873-83. PubMed ID: 6948081
    [No Abstract]   [Full Text] [Related]  

  • 22. Measurement of shear-activated platelet aggregate formation in non-anticoagulated blood: utility in detection of clopidogrel-aspirin-induced platelet dysfunction.
    Johnson GJ; Sharda AV; Rao GH; Ereth MH; Laxson DD; Owen WG
    Clin Appl Thromb Hemost; 2012; 18(2):140-9. PubMed ID: 22009986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RACAND syndrome as a paraneoplastic syndrome?
    El Mahou S; Sailler L; Madaule S; Arlet P
    J Clin Rheumatol; 2006 Apr; 12(2):104-5. PubMed ID: 16601551
    [No Abstract]   [Full Text] [Related]  

  • 24. A sex difference in the effect of aspirin on "spontaneous" platelet aggregation in whole blood.
    Harrison MJ; Weisblatt E
    Thromb Haemost; 1983 Dec; 50(4):773-4. PubMed ID: 6665757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-platelet effect of aspirin is substantially reduced after administration of heparin during carotid endarterectomy.
    Webster SE; Payne DA; Jones CI; Hayes PD; Bell PR; Goodall AH; Naylor AR
    J Vasc Surg; 2004 Sep; 40(3):463-8. PubMed ID: 15337874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment with antiplatelet drugs. Current status of knowledge].
    Dettori AG; Pini M; Quintavalla R
    Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of naftidrofuryl on platelet aggregation in plasma from aspirin treated patients: an in vitro study.
    Le Dévéhat C; Khodabandehlou T; Mosnier M
    Clin Hemorheol Microcirc; 2000; 22(3):197-204. PubMed ID: 10976713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.
    Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ
    Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus.
    Mortensen SB; Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Res; 2010 Oct; 126(4):e318-22. PubMed ID: 20451957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aspirin-like defect - a hereditary thrombocytopathy due to impaired release of platelet adenosine diphosphate].
    Elezović I; Mijović A; Rolović Z
    Bilt Hematol Transfuz; 1979; 7(2-3):165-74. PubMed ID: 263623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection.
    Modica A; Karlsson F; Mooe T
    J Thromb Haemost; 2007 Mar; 5(3):507-11. PubMed ID: 17319905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous platelet aggregation reversed by flurbiprofen.
    Politis-Tsegos C; Wolff S; Shaw S; Mitchell TR
    Br Med J; 1978 May; 1(6123):1323-4. PubMed ID: 647259
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial.
    Gardner CD; Zehnder JL; Rigby AJ; Nicholus JR; Farquhar JW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):787-93. PubMed ID: 17982321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravascular coagulation associated with pneumococcal bacteremia and symmetrical peripheral gangrene.
    Stossel TP; Levy R
    Arch Intern Med; 1970 May; 125(5):876-8. PubMed ID: 5424498
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influence of antiplatelet drugs (AD) on the efectiveness of combined therapy in patients with small cell lung cancer. Part I. Influence of AD on the haemostatic system].
    Ochmański W
    Przegl Lek; 2008; 65(6):288-98. PubMed ID: 18853660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Platelet aggregation inhibiting treatment with aspirin. Biological bases. Application to cerebral vascular accidents].
    Boneu B; Guiraud B; Fernet P
    Nouv Presse Med; 1972 Mar; 1(13):863-8. PubMed ID: 5018460
    [No Abstract]   [Full Text] [Related]  

  • 37. [Difficulties in evaluating the efficacy of antiplatelet therapy in clinical practice].
    Buriachkovskaia LI; Uchitel' IA; Sumarokov AV; Popov EG
    Ter Arkh; 2009; 81(5):41-7. PubMed ID: 19537585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of increased platelet anti-heparin factor in a patient with Raynaud's phenomena and gangrene, treated by aspirin.
    Fitzgerald DE; Butterfield WJ
    Angiology; 1969 Jun; 20(6):317-24. PubMed ID: 5789747
    [No Abstract]   [Full Text] [Related]  

  • 39. Bilateral simultaneous anterior ischaemic optic neuropathy associated with Sticky Platelet Syndrome.
    Mears KA; Van Stavern GP
    Br J Ophthalmol; 2009 Jul; 93(7):885-6, 913. PubMed ID: 18662911
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of naftidrofuryl and aspirin on platelet aggregation in peripheral vascular disease.
    Barradas MA; Stansby G; Hamilton G; Mikhailidis DP
    In Vivo; 1993; 7(6A):543-8. PubMed ID: 8193274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.